Clinical Trials Directory

Trials / Completed

CompletedNCT03828188

Efficacy and Safety of Red Ginseng Concentrated Powder on Improvement of Blood Triglyceride Level

A 12-week, Randomized, Double-blind, Placebo-controlled 2x2 Cross-over Design Human Trial to Evaluate the Efficacy and Safety of Red Ginseng Concentrated Powder on Improvement of Blood Triglyceride Level

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Chonbuk National University Hospital · Academic / Other
Sex
All
Age
19 Years – 70 Years
Healthy volunteers
Accepted

Summary

This study was conducted to investigate the effects of daily supplementation of Red Ginseng Concentrated Powder on Improvement of Blood Triglyceride Level.

Detailed description

This study was a 12-week, randomized, double-blind, placebo-controlled 2x2 cross-over design human trial. 50 subjects which of 25 by group were randomly divided into Red Ginseng Concentrated Powder and a placebo group.(A total of 100 subjects completed the 2x2 cross-over study.)

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTRed Ginseng Concentrated PowderRed Ginseng Concentrated Powder(4.9 g/day) for 12 weeks.
DIETARY_SUPPLEMENTPlaceboPlacebo for 12 weeks.

Timeline

Start date
2018-03-01
Primary completion
2018-05-11
Completion
2019-05-08
First posted
2019-02-04
Last updated
2020-05-08

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03828188. Inclusion in this directory is not an endorsement.